RVVTF - https://www.globenewswire.com/news-release/2020/07/31/2071110/0/en/Revive-Therapeutics-Announces-U-S-FDA-Approval-of-Confirmatory-Phase-3-Clinical-Trial-for-Bucillamine-in-COVID-19.html